Liver & Bile Duct Cancers

We provide innovative, evidence-based treatments for people with liver tumors, cancer that has spread to the liver from other organs, such as the colon, and bile duct cancer. Your team of experts includes hepatologists, who specialize in liver diseases, as well as medical oncologists, oncologic surgeons, interventional radiologists, nurses, social workers, and rehabilitation and palliative medicine specialists.

We create a personalized plan and offer modern diagnostic tools and advanced treatments, including specialized procedures performed before surgery to improve liver function. What’s more, we are home to one of the area’s premier centers for liver transplantation.

Clinical Trials and Research Studies

Phase 1

A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses

Learn More

Phase 4

Surefire vs. Endhole for DEB-TACE: Quantifying Hepatic Artery Embolization to Improve Outcomes (A Comparison of Two Different Catheter Systems for DEB-TACE)

Learn More

Phase 1/2

A PHASE 1/2 MULTICENTER OPEN-LABEL DOSE FINDING STUDY TO ASSESS THE SAFETY TOLERABILITY AND PRELIMINARY EFFICACY OF CC-122 IN COMBINATION WITH NIVOLUMAB IN SUBJECTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC)

Learn More

Phase 3

Treatment Of Children With All Stages Of Hepatoblastoma With Temsirolimus Added To High Risk Stratum Treatment

Learn More